AHG Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-0.480.0% YoY
Profit margin0.0%HEALTHCARE
Market cap$1.05BSmall cap

Valuation

Forward P/E
PEG ratio
P/B
5.31
P/S (TTM)
70.42
EV/EBITDA
-0.39

Profitability & growth

ROE (TTM)
-68.3%
Operating margin
-20.5%
Revenue growth YoY
0.9%
Dividend yield
Beta
-1.02
Last earnings
Feb 10, 2026 · Estimate $0.00 · Reported $0.00
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Akso Health Group ADR

Akso Health Group ADR is a leading innovator in the healthcare sector, focused on delivering advanced medical solutions and comprehensive patient care services. The company harnesses state-of-the-art health technologies to drive growth in areas such as telehealth and personalized medicine, supported by a strong emphasis on research and development. With a resilient business model and a dedicated team, Akso Health Group presents an attractive investment opportunity for institutional investors, poised to capitalize on the ongoing transformation within the healthcare industry.

Classification

Exchange
NASDAQ
Country
China
Currency
USD

Company profile

HQ
QIANTONGYUAN BUILDING, QINGDAO, CHINA
Fiscal year end
March
Latest quarter
Jun 30, 2025
Market cap$1.05B
Shares outstanding$854.0M
52W high$2.50
52W low$1.07

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer